Praxis Precision Medicines, Inc.
PRAX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,378 | $147 | $110 | $836 |
| - Cash | $215 | $81 | $62 | $139 |
| + Debt | $1 | $2 | $5 | $4 |
| Enterprise Value | $1,164 | $68 | $53 | $702 |
| Revenue | $9 | $2 | $0 | $0 |
| % Growth | 249.5% | – | – | – |
| Gross Profit | -$144 | -$84 | -$154 | $0 |
| % Margin | -1,682% | -3,445.8% | – | – |
| EBITDA | -$200 | -$126 | -$214 | -$167 |
| % Margin | -2,336.1% | -5,146.8% | – | – |
| Net Income | -$183 | -$123 | -$214 | -$167 |
| % Margin | -2,137.5% | -5,037.9% | – | – |
| EPS Diluted | -10.21 | -18.69 | -69.33 | -58.96 |
| % Growth | 45.4% | 73% | -17.6% | – |
| Operating Cash Flow | -$132 | -$111 | -$185 | -$125 |
| Capital Expenditures | $0 | -$0 | -$0 | -$1 |
| Free Cash Flow | -$132 | -$111 | -$185 | -$126 |